Natural Killer Cells During Primary Varicella Zoster Virus Infection.

Natural Killer Cells During Primary Varicella Zoster Virus Infection.

Opis bibliograficzny
Główni autorzy:	Malavige, G, Jones, L, Kamaladasa, S, Wijewickrama, A, Seneviratne, S, Black, A, Ogg, G
Format:	Journal article
Język:	English
Wydane:	2010

Podobne zapisy

Viral loads in primary varicella zoster virus infection
od: Malavige, G, i wsp.
Wydane: (2008)

Viral load, clinical disease severity and cellular immune responses in primary varicella zoster virus infection in Sri Lanka.
od: Malavige, G, i wsp.
Wydane: (2008)

Viral load, clinical disease severity and cellular immune responses in primary varicella zoster virus infection in Sri Lanka.
od: Gathsaurie Neelika Malavige, i wsp.
Wydane: (2008-01-01)

Immune evasion during varicella zoster virus infection of keratinocytes.
od: Black, A, i wsp.
Wydane: (2009)

Persistent high frequencies of varicella-zoster virus ORF4 protein-specific CD4+ T cells after primary infection.
od: Jones, L, i wsp.
Wydane: (2006)

Rapid effector function of varicella-zoster virus glycoprotein I-specific CD4+ T cells many decades after primary infection.
od: Malavige, G, i wsp.
Wydane: (2007)

Varicella-zoster virus vaccine is able to evade the T-cell response during the replicative phase of the viral life cycle
od: Black, A, i wsp.
Wydane: (2008)

Phenotypic analysis of human CD4+ T cells specific for immediate-early 63 protein of varicella-zoster virus.
od: Jones, L, i wsp.
Wydane: (2007)

Phenotypic analysis of human CD4+ T cells specific for immediate early 63 protein of varicella-zoster virus
od: Jones, L, i wsp.
Wydane: (2008)

Varicella zoster virus inhibition of toll-like receptor 3 signalling in keratinocytes - a novel immune evasion strategy
od: Black, A, i wsp.
Wydane: (2008)

Investigation of Varicella Zoster virus-specific T cell responses
od: Jones, L, i wsp.
Wydane: (2005)

Investigation of varicella zoster virus glycoprotein-specific T cell responses
od: Malavige, G, i wsp.
Wydane: (2007)

Varicella zoster virus productively infects human natural killer cells and manipulates phenotype.
od: Tessa Mollie Campbell, i wsp.
Wydane: (2018-04-01)

Varicella zoster virus glycoprotein E-specific CD4+ T cells show evidence of recent activation and effector differentiation, consistent with frequent exposure to replicative cycle antigens in healthy immune donors.
od: Malavige, G, i wsp.
Wydane: (2008)

Human antimicrobial peptides LL-37 and human β-defensin-2 reduce viral replication in keratinocytes infected with varicella zoster virus
od: Crack, L, i wsp.
Wydane: (2012)

Human antimicrobial peptides LL-37 and human β-defensin-2 reduce viral replication in keratinocytes infected with varicella zoster virus.
od: Crack, L, i wsp.
Wydane: (2012)

Clinical Features of Varicella-Zoster Virus Infection
od: Peter G. E. Kennedy, i wsp.
Wydane: (2018-11-01)

Seroprevalence of varicella zoster virus in Colombo district, Sri Lanka
od: Hathshya M Munasingha, i wsp.
Wydane: (2018-01-01)

IE63-specific T-cell responses associate with control of subclinical varicella zoster virus reactivation in individuals with malignancies.
od: Malavige, G, i wsp.
Wydane: (2010)

VARICELLA-ZOSTER VIRUS INFECTION IN PREGNANCY
od: Geta Vancea, i wsp.
Wydane: (2018-09-01)

The Role of Autophagy in Varicella Zoster Virus Infection
od: Johanna Heinz, i wsp.
Wydane: (2021-06-01)

Varicella zoster virus vaccines: an update
od: Gabutti G, i wsp.
Wydane: (2019-08-01)

Animal Models of Varicella Zoster Virus Infection
od: Ilhem Messaoudi, i wsp.
Wydane: (2013-05-01)

The epidemiology of Varicella Zoster Virus infection in Italy
od: Ciofi degli Atti Marta L, i wsp.
Wydane: (2008-10-01)

Simian Varicella Virus Pathogenesis in Skin during Varicella and Zoster
od: Ravi Mahalingam, i wsp.
Wydane: (2022-05-01)

Varicella Zoster Virus Vasculopathies
od: J Gordon Millichap
Wydane: (2008-03-01)

Varicella Zoster Virus Encephalitis
od: Jared Lizzi, i wsp.
Wydane: (2019-11-01)

Etymologia: Varicella Zoster Virus
Wydane: (2015-04-01)

Varicella zoster virus encephalitis in an immunocompetent woman
od: G.R. Yilmaz, i wsp.
Wydane: (2014-04-01)

Preventing varicella zoster infection in immunocompromised adults with varicella zoster–specific immunoglobulins
od: Daniel Gelman, i wsp.
Wydane: (2023-01-01)

The frequency of transplacental Varicella-Zoster Virus transmission after primary maternal infection
od: Isaković Vuk, i wsp.
Wydane: (2020-01-01)

Perinatal Chicken Pox (Varicella Zoster Virus) Infection
od: Ali Annagur, i wsp.
Wydane: (2013-01-01)

Swiss recommendations for the management of varicella zoster virus infections
od: R Agosti
Wydane: (2007-05-01)

Advances and Perspectives in the Management of Varicella-Zoster Virus Infections
od: Graciela Andrei, i wsp.
Wydane: (2021-02-01)

Hair Loss after Varicella Zoster Virus Infection
od: Lara El Hayderi, i wsp.
Wydane: (2013-02-01)

Varicella-zoster virus infections – antiviral therapy and diagnosis
od: Sauerbrei, Andreas
Wydane: (2016-02-01)

Cutaneous varicella zoster virus infection: an assocation with ibuprofen?
od: Joana Jorge Antunes, i wsp.
Wydane: (2019-10-01)

The nature of lesions of the central nervous system in infections, caused by <i>Varicella Zoster</i> virus
od: S. N. Eshmolov, i wsp.
Wydane: (2023-11-01)

Pneumonia a Varicella zoster Varicella zoster pneumonia
od: Carla Ferreira Santos, i wsp.
Wydane: (2010-06-01)

Comparative Analysis of the Simian Varicella Virus and Varicella Zoster Virus Genomes
od: Wayne L. Gray
Wydane: (2022-04-01)